Advertisement
(Photo: http://www.newscom.com/cgi-bin/prnh/20080613/AQF014)
"I am thrilled to join Coapt Systems as its President and CEO and to helpthe company achieve even greater success by taking advantage of new marketopportunities," said DeBuono. "Coapt has established itself as a market leaderand innovator, and the company has steadily increased its product offeringsand customer base. Coapt is now poised to expand its innovative product lineand to move into new markets, particularly non-invasive aesthetics."
Advertisement
The company has introduced seven products into the market since 2002, andover 65,000 patients worldwide have received ENDOTINE(TM) implants in facialrejuvenation procedures. The Company's products are sold in over 41countries.
Coapt Systems, founded in 2000 by a practicing plastic surgeon, designs,develops, manufactures, and markets bio absorbable implants that providesurgeons with breakthrough soft tissue fixation technology. Coapt'srevolutionary platform technology for soft tissue fixation enables surgeons toreduce operating time, facilitate minimally invasive procedures, minimizeprocedural complexity, and achieve improved surgical outcomes. Coapt'spatented ENDOTINE family of products are used for plastic surgery proceduresthat require accurate soft tissue fixation either to opposing soft tissue orto bone. The ENDOTINE product line is becoming the standard of care inaesthetic facial procedures.
"Coapt Systems has all the necessary elements, including strong managementand an innovative product line, to continue its strong pace of growth andexpansion," said Brent Ahrens, general partner at Canaan Partners. "Coapt isa great example of the type of innovative, high-growth company meeting unmetmedical needs we invest in at Canaan. Laureen is a great addition to the teamwith her extensive management experience and recent success in the growingfield of non-invasive aesthetics. Under her leadership, Coapt is poised toachieve even greater success moving forward."
Prior to joining Thermage in 2003, DeBuono was a consulting EVP and CFO toseveral public and private technology and medical device companies. DeBuonowas also EVP, COO and CFO of More.com, an Internet health products commercecompany, and she was EVP, COO and CFO of Resound Corporation, a public,hearing products and communications company that was acquired by GN GreatNordic in 1999. She also served as EVP, General Counsel to Nellcor PuritanBennett Inc., a $900M public respiratory products company, from 1992-1998, andnegotiated the sale of the company to Mallinkcrodt, Inc. in 1998. She was amember of the Board of Directors of Invivo, Inc., a public patient safetymonitoring company, from 1998-2004, and of VISX, Inc., a public visioncorrection company, from 2003-2005, both of which were acquired. DeBuonoreceived her J.D. from New York University Law School, an M.A. from StanfordUniversity and a B.A. from Duke University.
About Coapt Systems
Coapt's product lineup includes the ENDOTINE Forehead, Midface ST, MidfaceB, TransBleph, Triple, Ribbon and SurgiWi
